Search Legislation

Medicines and Medical Devices Act 2021

 Help about what version

What Version

 Help about advanced features

Advanced Features

Changes over time for: Section 39

 Help about opening options

Changes to legislation:

There are currently no known outstanding effects for the Medicines and Medical Devices Act 2021, Section 39. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

39Disclosure of informationU.K.
This section has no associated Explanatory Notes

(1)This section applies in relation to information which the Secretary of State holds in connection with medical devices.

(2)The Secretary of State may disclose information for the purpose of warning members of the public about concerns that the Secretary of State has in relation to the safety of a medical device.

(3)The Secretary of State may disclose information to a person who provides services or exercises functions relating to medical devices for the purposes of—

(a)enabling or facilitating the exercise by the Secretary of State of a function relating to medical devices;

(b)enabling or facilitating the exercise by another person of a function relating to medical devices;

(c)enabling or facilitating the provision of a service relating to medical devices by another person.

(4)The Secretary of State may disclose information for the purposes of—

(a)civil proceedings;

(b)criminal investigations or proceedings.

(5)The Secretary of State may disclose information to a relevant person outside the United Kingdom where—

(a)the disclosure is required for the purpose of giving effect to an international agreement or arrangement concerning the regulation of medical devices, and

(b)the Secretary of State considers that the disclosure is in the public interest.

(6)But subsection (5) does not authorise a disclosure of patient information without the consent of the individual to whom that information relates.

(7)The Secretary of State may not disclose commercially sensitive information in reliance on subsection (2), (3), (4) or (5) unless the Secretary of State—

(a)considers that it is necessary to do so for one or more of the purposes mentioned in subsection (2), (3), (4) or (5), and

(b)is satisfied that the making of the disclosure is proportionate to what is sought to be achieved by it.

(8)Where information to which this section applies is disclosed to a person in reliance on subsection (3) or (4), the person may not use or further disclose the information except—

(a)with the agreement of the Secretary of State and for a purpose mentioned in subsection (3) or (4), or

(b)in accordance with an enactment or order of a court or tribunal.

(9)Except as provided by subsection (10), the disclosure of information in accordance with this section does not breach—

(a)an obligation of confidence owed by the person making the disclosure, or

(b)any other restriction on the disclosure of the information (however imposed).

(10)Nothing in this section authorises a disclosure of information which—

(a)contravenes the data protection legislation (but in determining whether a disclosure would do so, take into account the powers conferred by this section), F1...

(b)is prohibited by any of Parts 1 to 7 or Chapter 1 of Part 9 of the Investigatory Powers Act 2016 [F2, or]

[F2(c)contravenes any obligation or restriction created or arising by or under the Protocol on Ireland/Northern Ireland in the EU withdrawal agreement, whether or not an obligation or restriction to which section 7A(2) of the European Union (Withdrawal) Act 2018 applies.]

(11)This section does not limit the circumstances in which information may be disclosed under any other enactment or rule of law.

(12)In this section—

  • commercially sensitive information” means commercial information whose disclosure the Secretary of State thinks might significantly harm the legitimate business interests of the undertaking to which it relates;

  • patient information” means information (however recorded) which—

    (a)

    relates to—

    (i)

    the physical or mental health or condition of an individual,

    (ii)

    the diagnosis of an individual's condition, or

    (iii)

    an individual's care or treatment,

    or is (to any extent) derived directly or indirectly from information relating to any of those matters, and

    (b)

    identifies the individual or enables the individual to be identified (whether by itself or in combination with other information);

  • relevant person” means—

    (a)

    the government of a country or territory outside the United Kingdom;

    (b)

    a person who exercises functions on behalf of such a government;

    (c)

    any other person who exercises functions or provides services relating to medical devices in a country or territory outside the United Kingdom;

    (d)

    an international organisation that exercises functions or provides services relating to medical devices.

Textual Amendments

Commencement Information

I1S. 39 in force at 26.5.2021 by S.I. 2021/610, reg. 2(b)

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Notes

Text created by the government department responsible for the subject matter of the Act to explain what the Act sets out to achieve and to make the Act accessible to readers who are not legally qualified. Explanatory Notes were introduced in 1999 and accompany all Public Acts except Appropriation, Consolidated Fund, Finance and Consolidation Acts.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources